

HVJQ+8F9, Phnom Penh, Cambodia
Acriptega 50 mg / 300 mg / 300 mg
Prescription notice
Item may require a valid prescription. Please consult your doctor or pharmacist before using new medication.
Last updated 28/08/2026 at 5:12 PM

HVJQ+8F9, Phnom Penh, Cambodia
Indication
Treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents weighing at least 35 kg, as a complete fixed-dose combination antiretroviral regimen.
Ingredients
- Dolutegravir
- Lamivudine
- Tenofovir disoproxil fumarate
Direction
Adults and adolescents weighing at least 35 kg: 1 film-coated tablet (50 mg dolutegravir / 300 mg lamivudine / 300 mg tenofovir disoproxil fumarate) once daily, taken orally with or without food. As directed by the physician; do not exceed the prescribed dose.
Side effects
- Headache
- nausea
- diarrhoea
- fatigue.
- Insomnia
- dizziness.
- Rash and other allergic skin reactions.
- Possible changes in liver and kidney function
- decreased bone mineral density with long
- term use.
- Stop and consult a doctor or pharmacist immediately if any unusual or severe reaction occurs.
Precautions
- Prescription only
- use only under medical supervision.
- Inform your doctor of all medicines you take
- including herbal products and antacids
- due to risk of interactions.
- Use with caution in patients with kidney disease
- hepatitis B or C co
- infection
- or osteoporosis.
- Use during pregnancy and breastfeeding only on the advice of a doctor.
- Contains lactose
- not suitable for patients with lactose intolerance.
- Adhere strictly to the prescribed dose and schedule to maintain effectiveness.
- Consult a doctor or pharmacist before use
- stop and seek advice if irritation or allergy occurs.
Indication
Treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents weighing at least 35 kg, as a complete fixed-dose combination antiretroviral regimen.
Ingredients
- Dolutegravir
- Lamivudine
- Tenofovir disoproxil fumarate
Direction
Adults and adolescents weighing at least 35 kg: 1 film-coated tablet (50 mg dolutegravir / 300 mg lamivudine / 300 mg tenofovir disoproxil fumarate) once daily, taken orally with or without food. As directed by the physician; do not exceed the prescribed dose.
Side effects
- Headache
- nausea
- diarrhoea
- fatigue.
- Insomnia
- dizziness.
- Rash and other allergic skin reactions.
- Possible changes in liver and kidney function
- decreased bone mineral density with long
- term use.
- Stop and consult a doctor or pharmacist immediately if any unusual or severe reaction occurs.
Precautions
- Prescription only
- use only under medical supervision.
- Inform your doctor of all medicines you take
- including herbal products and antacids
- due to risk of interactions.
- Use with caution in patients with kidney disease
- hepatitis B or C co
- infection
- or osteoporosis.
- Use during pregnancy and breastfeeding only on the advice of a doctor.
- Contains lactose
- not suitable for patients with lactose intolerance.
- Adhere strictly to the prescribed dose and schedule to maintain effectiveness.
- Consult a doctor or pharmacist before use
- stop and seek advice if irritation or allergy occurs.
You may also like
Similar medicines from PHARMA ASSIST PHARMACY

POSTPIL 1.5 mg
PHARMA ASSIST PHARMACY
Prescription requiredContact pharmacy for pricing

KLEN Intimate Wash Extra Cool 50 mL
PHARMA ASSIST PHARMACY
$2.00

Cerebrofort Gold Per 15 mL serving: Fish oil 15 mg, AA, DHA 50 mg, EPA 10 mg, L-Glutamic acid 2 mg, Folic acid 50 mcg, Biotin 100 mcg, L-Lysine HCl 0.2 mg, Vitamin B1 50 mg, Vitamin B2 1.5 mg, Vitamin B6 1.5 mg, Vitamin A 1300 IU, Vitamin D3 200 IU
PHARMA ASSIST PHARMACY
$3.15

Doxycap 100 mg
PHARMA ASSIST PHARMACY
Prescription required$0.20